Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers

Peter Bannas, Harald Kramer, Diego Hernando, Rashmi Agni, Ashley M. Cunningham, Rakesh Mandal, Utaroh Motosugi, Samir D. Sharma, Alejandro Munoz del Rio, Luis Fernandez, Scott B. Reeder – 29 July 2015 – Emerging magnetic resonance imaging (MRI) biomarkers of hepatic steatosis have demonstrated tremendous promise for accurate quantification of hepatic triglyceride concentration. These methods quantify the proton density fat‐fraction (PDFF), which reflects the concentration of triglycerides in tissue.

Impact of the serum ferritin concentration in liver transplantation

Taiichi Wakiya, Yukihiro Sanada, Taizen Urahashi, Yoshiyuki Ihara, Naoya Yamada, Noriki Okada, Yuta Hirata, Kenichi Hakamada, Yoshikazu Yasuda, Koichi Mizuta – 29 July 2015 – The serum ferritin (SF) concentration is a widely available and objective laboratory parameter. SF is also widely recognized as an acute‐phase reactant. The purpose of the present study was to identify the chronological changes in the recipient's SF concentration during liver transplantation (LT) and to clarify factors having an effect on the recipient's intraoperative SF level.

Subscribe to